Advertisement
U.S. markets open in 1 hour 35 minutes
S&P Futures
6,001.75 -2.00 (-0.03%) Dow Futures
43,930.00 +20.00 (+0.05%) Nasdaq Futures
21,184.50 -40.25 (-0.19%) Russell 2000 Futures
2,391.70 -4.00 (-0.17%) Crude Oil
71.09 -1.27 (-1.76%) Gold
2,697.80 -8.00 (-0.30%)
Zealand Pharma A/S (ZEAL.CO)
Copenhagen - Copenhagen Real Time Price. Currency in DKK
Follow
As of 01:55PM CET. Market open.
| Previous Close | 813.50 |
| Open | 847.00 |
| Bid | 840.00 x 0 |
| Ask | 839.50 x 0 |
| Day's Range | 838.50 - 883.00 |
| 52 Week Range | 274.40 - 972.00 |
| Volume | |
| Avg. Volume | 246,562 |
| Market Cap | 59.379B |
| Beta (5Y Monthly) | 0.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -16.76 |
| Earnings Date | Nov 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1,003.10 |
GuruFocus.comZealand Pharma AS (ZLDPF) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Financial ...
Zealand Pharma AS (ZLDPF) showcases promising trial results and strategic partnerships while navigating high R&D expenses and regulatory hurdles.
ZacksZealand Pharma A/S (ZLDPF) Reports Q3 Loss, Lags Revenue Estimates
Zealand Pharma AS (ZLDPF) delivered earnings and revenue surprises of 9.68% and 75.75%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.